Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Howard Hughes (HHH) Competitors

Howard Hughes logo
$63.75 -0.77 (-1.20%)
Closing price 03:59 PM Eastern
Extended Trading
$63.71 -0.04 (-0.05%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HHH vs. TSHA, OWL, REG, GLPI, and DOC

Should you buy Howard Hughes stock or one of its competitors? MarketBeat compares Howard Hughes with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Howard Hughes include Taysha Gene Therapies (TSHA), Blue Owl Capital (OWL), Regency Centers (REG), Gaming and Leisure Properties (GLPI), and Healthpeak Properties (DOC).

How does Howard Hughes compare to Taysha Gene Therapies?

Taysha Gene Therapies (NASDAQ:TSHA) and Howard Hughes (NYSE:HHH) are related companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

In the previous week, Howard Hughes had 5 more articles in the media than Taysha Gene Therapies. MarketBeat recorded 6 mentions for Howard Hughes and 1 mentions for Taysha Gene Therapies. Taysha Gene Therapies' average media sentiment score of 0.00 beat Howard Hughes' score of -0.12 indicating that Taysha Gene Therapies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Taysha Gene Therapies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Howard Hughes
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

77.7% of Taysha Gene Therapies shares are owned by institutional investors. Comparatively, 93.8% of Howard Hughes shares are owned by institutional investors. 3.8% of Taysha Gene Therapies shares are owned by company insiders. Comparatively, 48.0% of Howard Hughes shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Taysha Gene Therapies has a beta of 1.25, indicating that its share price is 25% more volatile than the broader market. Comparatively, Howard Hughes has a beta of 1.15, indicating that its share price is 15% more volatile than the broader market.

Taysha Gene Therapies currently has a consensus price target of $11.64, indicating a potential upside of 111.96%. Howard Hughes has a consensus price target of $85.00, indicating a potential upside of 33.34%. Given Taysha Gene Therapies' stronger consensus rating and higher possible upside, equities analysts clearly believe Taysha Gene Therapies is more favorable than Howard Hughes.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Taysha Gene Therapies
1 Sell rating(s)
0 Hold rating(s)
10 Buy rating(s)
2 Strong Buy rating(s)
3.00
Howard Hughes
2 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.75

Howard Hughes has a net margin of 8.04% compared to Taysha Gene Therapies' net margin of 0.00%. Howard Hughes' return on equity of 5.41% beat Taysha Gene Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Taysha Gene TherapiesN/A -56.07% -40.16%
Howard Hughes 8.04%5.41%1.61%

Howard Hughes has higher revenue and earnings than Taysha Gene Therapies. Taysha Gene Therapies is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Taysha Gene Therapies$9.77M161.47-$109M-$0.38N/A
Howard Hughes$1.47B2.58$131.88M$2.0431.25

Summary

Howard Hughes beats Taysha Gene Therapies on 9 of the 16 factors compared between the two stocks.

How does Howard Hughes compare to Blue Owl Capital?

Blue Owl Capital (NYSE:OWL) and Howard Hughes (NYSE:HHH) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

Howard Hughes has a net margin of 8.04% compared to Blue Owl Capital's net margin of 2.96%. Blue Owl Capital's return on equity of 21.97% beat Howard Hughes' return on equity.

Company Net Margins Return on Equity Return on Assets
Blue Owl Capital2.96% 21.97% 10.79%
Howard Hughes 8.04%5.41%1.61%

Howard Hughes has lower revenue, but higher earnings than Blue Owl Capital. Howard Hughes is trading at a lower price-to-earnings ratio than Blue Owl Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Blue Owl Capital$2.87B5.46$78.83M$0.1283.95
Howard Hughes$1.47B2.58$131.88M$2.0431.25

Blue Owl Capital has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market. Comparatively, Howard Hughes has a beta of 1.15, indicating that its share price is 15% more volatile than the broader market.

Blue Owl Capital presently has a consensus target price of $14.50, suggesting a potential upside of 43.93%. Howard Hughes has a consensus target price of $85.00, suggesting a potential upside of 33.34%. Given Blue Owl Capital's stronger consensus rating and higher possible upside, equities research analysts plainly believe Blue Owl Capital is more favorable than Howard Hughes.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Blue Owl Capital
1 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.50
Howard Hughes
2 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.75

In the previous week, Blue Owl Capital had 8 more articles in the media than Howard Hughes. MarketBeat recorded 14 mentions for Blue Owl Capital and 6 mentions for Howard Hughes. Blue Owl Capital's average media sentiment score of 0.10 beat Howard Hughes' score of -0.12 indicating that Blue Owl Capital is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Blue Owl Capital
1 Very Positive mention(s)
1 Positive mention(s)
10 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Howard Hughes
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

35.9% of Blue Owl Capital shares are owned by institutional investors. Comparatively, 93.8% of Howard Hughes shares are owned by institutional investors. 25.7% of Blue Owl Capital shares are owned by insiders. Comparatively, 48.0% of Howard Hughes shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Blue Owl Capital beats Howard Hughes on 11 of the 17 factors compared between the two stocks.

How does Howard Hughes compare to Regency Centers?

Regency Centers (NASDAQ:REG) and Howard Hughes (NYSE:HHH) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

In the previous week, Regency Centers and Regency Centers both had 6 articles in the media. Regency Centers' average media sentiment score of 0.23 beat Howard Hughes' score of -0.12 indicating that Regency Centers is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Regency Centers
1 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Howard Hughes
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Regency Centers has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market. Comparatively, Howard Hughes has a beta of 1.15, indicating that its stock price is 15% more volatile than the broader market.

96.1% of Regency Centers shares are owned by institutional investors. Comparatively, 93.8% of Howard Hughes shares are owned by institutional investors. 1.0% of Regency Centers shares are owned by company insiders. Comparatively, 48.0% of Howard Hughes shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Regency Centers has higher revenue and earnings than Howard Hughes. Regency Centers is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Regency Centers$1.55B9.29$527.46M$2.9027.19
Howard Hughes$1.47B2.58$131.88M$2.0431.25

Regency Centers has a net margin of 34.47% compared to Howard Hughes' net margin of 8.04%. Regency Centers' return on equity of 7.99% beat Howard Hughes' return on equity.

Company Net Margins Return on Equity Return on Assets
Regency Centers34.47% 7.99% 4.22%
Howard Hughes 8.04%5.41%1.61%

Regency Centers currently has a consensus price target of $81.71, suggesting a potential upside of 3.65%. Howard Hughes has a consensus price target of $85.00, suggesting a potential upside of 33.34%. Given Howard Hughes' higher probable upside, analysts clearly believe Howard Hughes is more favorable than Regency Centers.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Regency Centers
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.47
Howard Hughes
2 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.75

Summary

Regency Centers beats Howard Hughes on 12 of the 16 factors compared between the two stocks.

How does Howard Hughes compare to Gaming and Leisure Properties?

Howard Hughes (NYSE:HHH) and Gaming and Leisure Properties (NASDAQ:GLPI) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

93.8% of Howard Hughes shares are held by institutional investors. Comparatively, 91.1% of Gaming and Leisure Properties shares are held by institutional investors. 48.0% of Howard Hughes shares are held by company insiders. Comparatively, 4.1% of Gaming and Leisure Properties shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Gaming and Leisure Properties had 3 more articles in the media than Howard Hughes. MarketBeat recorded 9 mentions for Gaming and Leisure Properties and 6 mentions for Howard Hughes. Gaming and Leisure Properties' average media sentiment score of 1.26 beat Howard Hughes' score of -0.12 indicating that Gaming and Leisure Properties is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Howard Hughes
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Gaming and Leisure Properties
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Howard Hughes currently has a consensus target price of $85.00, suggesting a potential upside of 33.34%. Gaming and Leisure Properties has a consensus target price of $52.50, suggesting a potential upside of 9.88%. Given Howard Hughes' higher possible upside, analysts plainly believe Howard Hughes is more favorable than Gaming and Leisure Properties.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Howard Hughes
2 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.75
Gaming and Leisure Properties
0 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Howard Hughes has a beta of 1.15, meaning that its stock price is 15% more volatile than the broader market. Comparatively, Gaming and Leisure Properties has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market.

Gaming and Leisure Properties has higher revenue and earnings than Howard Hughes. Gaming and Leisure Properties is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Howard Hughes$1.47B2.58$131.88M$2.0431.25
Gaming and Leisure Properties$1.59B8.49$825.11M$3.1515.17

Gaming and Leisure Properties has a net margin of 55.56% compared to Howard Hughes' net margin of 8.04%. Gaming and Leisure Properties' return on equity of 18.06% beat Howard Hughes' return on equity.

Company Net Margins Return on Equity Return on Assets
Howard Hughes8.04% 5.41% 1.61%
Gaming and Leisure Properties 55.56%18.06%6.93%

Summary

Gaming and Leisure Properties beats Howard Hughes on 11 of the 16 factors compared between the two stocks.

How does Howard Hughes compare to Healthpeak Properties?

Healthpeak Properties (NYSE:DOC) and Howard Hughes (NYSE:HHH) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

In the previous week, Howard Hughes had 2 more articles in the media than Healthpeak Properties. MarketBeat recorded 6 mentions for Howard Hughes and 4 mentions for Healthpeak Properties. Healthpeak Properties' average media sentiment score of 0.52 beat Howard Hughes' score of -0.12 indicating that Healthpeak Properties is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Healthpeak Properties
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Howard Hughes
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

93.6% of Healthpeak Properties shares are held by institutional investors. Comparatively, 93.8% of Howard Hughes shares are held by institutional investors. 0.2% of Healthpeak Properties shares are held by insiders. Comparatively, 48.0% of Howard Hughes shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Healthpeak Properties currently has a consensus price target of $19.08, suggesting a potential downside of 3.34%. Howard Hughes has a consensus price target of $85.00, suggesting a potential upside of 33.34%. Given Howard Hughes' higher probable upside, analysts plainly believe Howard Hughes is more favorable than Healthpeak Properties.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Healthpeak Properties
0 Sell rating(s)
10 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.33
Howard Hughes
2 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.75

Howard Hughes has a net margin of 8.04% compared to Healthpeak Properties' net margin of 7.73%. Howard Hughes' return on equity of 5.41% beat Healthpeak Properties' return on equity.

Company Net Margins Return on Equity Return on Assets
Healthpeak Properties7.73% 2.61% 1.09%
Howard Hughes 8.04%5.41%1.61%

Healthpeak Properties has a beta of 1, suggesting that its share price has a similar volatility profile to the broader market.Comparatively, Howard Hughes has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market.

Howard Hughes has lower revenue, but higher earnings than Healthpeak Properties. Howard Hughes is trading at a lower price-to-earnings ratio than Healthpeak Properties, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Healthpeak Properties$2.82B4.82$71.35M$0.3261.68
Howard Hughes$1.47B2.58$131.88M$2.0431.25

Summary

Howard Hughes beats Healthpeak Properties on 10 of the 16 factors compared between the two stocks.

Get Howard Hughes News Delivered to You Automatically

Sign up to receive the latest news and ratings for HHH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HHH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HHH vs. The Competition

MetricHoward HughesREAL ESTATE DEV IndustryFinance SectorNYSE Exchange
Market Cap$3.85B$3.19B$13.58B$23.12B
Dividend YieldN/A6.70%5.84%4.11%
P/E Ratio23.908.4723.9530.63
Price / Sales2.582.98150.0814.47
Price / Cash10.4023.0920.0924.79
Price / Book1.291.052.144.74
Net Income$131.88M-$7.05M$1.13B$1.07B
7 Day Performance-0.17%-0.29%0.79%1.94%
1 Month Performance-1.50%-4.78%-0.28%0.38%
1 Year Performance-4.87%13.75%11.85%28.11%

Howard Hughes Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HHH
Howard Hughes
3.1793 of 5 stars
$63.75
-1.2%
$85.00
+33.3%
-3.0%$3.85B$1.47B23.90608
TSHA
Taysha Gene Therapies
2.5176 of 5 stars
$5.30
-2.8%
$11.64
+119.8%
+91.7%$1.52B$9.77MN/A180
OWL
Blue Owl Capital
4.5018 of 5 stars
$9.43
-0.7%
$15.03
+59.5%
-43.6%$14.65B$2.87B78.541,365
REG
Regency Centers
3.7466 of 5 stars
$77.14
-0.3%
$81.71
+5.9%
+9.8%$14.10B$1.55B26.55440
GLPI
Gaming and Leisure Properties
3.8929 of 5 stars
$47.59
+0.8%
$52.50
+10.3%
+2.4%$13.46B$1.62B15.0820

Related Companies and Tools


This page (NYSE:HHH) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners